Millipore Sigma Vibrant Logo

MABC980 Anti-PD-L1 Antibody, clone 29E.2A3.C6, Azide Free

Anti-PD-L1 Antibody, clone 29E.2A3.C6, Azide Free is an antibody against PD-L1 for use in Immunohistochemistry (Paraffin), Flow Cytometry, Neutralizing, Immunocytochemistry.

FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.
Research Category: Apoptosis & Cancer Research Sub-Category: Apoptosis - Additional Gene Symbol: CD274, B7H1, PDCD1L1, PDCD1LG1, PDL1 UniProt Number: Q9NZQ7
View Products on Sigmaaldrich.com
MABC980
100 μg  
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
—
Demander le prix
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      Offres spéciales

       

      Contacter le Service Clients

      Aperçu

      Replacement Information

      Offres spéciales

      100% Performance Guaranteed

      Tableau de caractéristiques principal

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      H, R, ChpIH(P), FC, NEUT, ICCMPurifiedMonoclonal Antibody
      Description
      Catalogue NumberMABC980
      DescriptionAnti-PD-L1 Antibody, clone 29E.2A3.C6, Azide Free
      Alternate Names
      • Programmed cell death 1 ligand 1
      • B7-H1
      • B7 homolog 1
      • CD274
      • PD-L1
      • PDCD1 ligand 1
      • Programmed death ligand 1
      Background InformationProgrammed cell death 1 ligand 1 (UniProt Q9NZQ7; also known as B7-H1, B7 homolog 1, CD274, PD-L1, PDCD1 ligand 1, Programmed death ligand 1) is encoded by the CD274 (also known as B7H1, PDCD1L1, PDCD1LG1, PDL1) gene (Gene ID 29126) in human. PD-1 and PD-1 ligands 1&2 (PD-L1 and PD-L2) are B7:CD28 family members that regulate T cell activation and peripheral tolerance. When engaged together with the TCR, the interaction of PD-1 with its ligands delivers an inhibitory signal to T cell proliferation and cytokine production. While PD-L1 is broadly expressed in hematopoietic and nonhematopoietic cells, PD-L2 expression is highly restricted to antigen presenting cells (APCs), including dendritic cells (DCs) and macrophages. The PD-1 pathway plays a key role in the progressive loss of effector T cell responses during chronic HIV infection. Under some conditions, blockade of this pathway is able to restore many T cell functions. PD-L1 is initially produced with signal peptide (a.a. 1-18) sequence, the removal of which yields the mature protien with a large extracellular (a.a. 19-238) region that contains an Ig-like V-type domain (a.a. 19-127) and an Ig-like C2-type domain (a.a. 133-225), followed by a transmembrane domain (a.a. 239-259) and a cytoplasmic tail (a.a. 260-290).
      References
      Product Information
      FormatPurified
      PresentationPurified mouse monoclonal IgG2bκ antibody in PBS without preservatives.
      Quality LevelMQ100
      Applications
      ApplicationAnti-PD-L1 Antibody, clone 29E.2A3.C6, Azide Free is an antibody against PD-L1 for use in Immunohistochemistry (Paraffin), Flow Cytometry, Neutralizing, Immunocytochemistry.
      Key Applications
      • Immunohistochemistry (Paraffin)
      • Flow Cytometry
      • Neutralizing
      • Immunocytochemistry
      Application NotesImmunohistochemistry Analysis: An 1:50 dilution of this antibody from a representative lot detected PD-L1 in human kidney and rat colon tissue.
      Flow Cytometry Analysis: 0.1 µg of this antibody from a representative lot detected PD-L1 in MDA-MB-231 cells.
      Flow Cytometry Analysis: A representative lot immunostained the surface of 300.19 murine pre-B lymphoma cells transfected with human PD-L1, but not the untransfected cells or cells transfected with human PD-L2 (Brown, J.A., et al. (2003). J. Immunol. 170(3):1257-1266).
      Flow Cytometry Analysis: A representative lot detected surface PD-L1 expression on human breast cancer cell lines MDA-231, SKBR-3, and MCF-7, but not BT-474 (Latchman, Y., et al. (2001). J. Nat. Immunol.2(3):261-268).
      Immunohistochemistry Analysis: A representative lot detected PD-L1 expression pattern in frozen fetal (thymus & cardiac tissue) and paraffin-embedded adult (tonsillar germinal center and placenta) human tissue sections (Brown, J.A., et al. (2003). J. Immunol. 170(3):1257-1266).
      Immunohistochemistry Analysis: A representative lot detected PD-L1 expression in paraffin-embedded human cancer tissue sections, including anaplastic large cell lymphoma, squamous cell carcinoma of the tongue, colon adenocarcinoma, and invasive breast ductal carcinoma (Brown, J.A., et al. (2003). J. Immunol. 170(3):1257-1266).
      Neutralizing Analysis: A representative lot competed against human PD-1 extracellular domain Ig fusion for the binding of exogenously expressed human PD-L1 on the surface of 300.19 murine pre-B lymphoma cells (Brown, J.A., et al. (2003). J. Immunol. 170(3):1257-1266).
      Neutralizing Analysis: A representative lot enhanced cytokines production from CD4 T-cells upon HIV Gag peptides stimulation of CD8+-depleted human PBMCs (Porichis, F., et al. (2011). Blood. 118(4):965-974).
      Neutralizing Analysis: A representative lot restored HCV peptides-induced expansion of CD8+ T cells in cultured intrahepatic lymphocytes from a chimpanzee with 10 years of chronic HCV infection (Fuller, M.J., et al. (2013). Proc. Natl. Acad. Sci. U. S. A. 110(37):15001-15006).
      Neutralizing Analysis: Dual blockage of both DP-L1 clone 29E.2A3.C6 Fab fragment and DP-L2 by clone 24F.10C12 (Cat. No. MABC969) Fab fragment on PBMC-derived dendric cells (DCs) boosted the enhancing effect on CD4+ T-cell proliferation and cytokine release seen with DP-L2 blockage alone in allogenic cultures with immature DCs (iDC), mature DCs (mDC), and IL-10-treated mDCs (Brown, J.A., et al. (2003). J. Immunol. 170(3):1257-1266).
      Immunocytochemistry Analysis: A representative lot detected an upregulated PD-L1 immunoreactivity in human CD14+ monocyte-derived macrophages (MDMs) following HIV infection or TLR4/8 stimulation (by LPS or CL097 treatment) by fluorescent immunocytochemistry using paraformaldehyde-fixed MDMs (Rodríguez-García, M., et al. (2011). J. Leukoc. Biol. 89(4) 507–515).
      Biological Information
      ImmunogenRecombinant full-length human PD-L1.
      EpitopeExtracellular domain.
      Clone29E.2A3.C6
      ConcentrationPlease refer to lot specific datasheet.
      HostMouse
      SpecificityClone 29E.2A3.C6 immunostained the surface of 300.19 murine pre-B lymphoma cells transfected with human PD-L1, but not the untransfected cells or cells transfected with human PD-L2 (Brown, J.A., et al. (2003). J. Immunol. 170(3):1257-1266). Reactivity toward spliced isoform 2 (PD-L1II) and isoform 3 has not been determined.
      IsotypeIgG2bκ
      Species Reactivity
      • Human
      • Rat
      • Chimpanzee
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • CD274
      • B7H1
      • PDCD1L1
      • PDCD1LG1
      • PDL1
      Purification MethodProtein G Purified
      UniProt Number
      Molecular Weight31.02 kDa (isoform 1; PD-L1I), 17.99 kDa (isoform 2; PD-L1II), 18.20 kDa (isoform 3) calculated.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Immunohistochemistry in human cerebral cortex tissue.

      Immunohistochemistry Analysis: An 1:50 dilution of this antibody detected PD-L1 in human cerebral cortex tissue.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at -20°C from date of receipt.
      Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
      Packaging Information
      Material Size100 μg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      MABC980 04055977330342

      Documentation

      Anti-PD-L1 Antibody, clone 29E.2A3.C6, Azide Free FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Anti-PD-L1 Antibody, clone 29E.2A3.C6, Azide Free Certificats d'analyse

      TitreNuméro de lot
      Anti-PD-L1, clone 29E.2A3.C6, -Q2659762 Q2659762
      Anti-PD-L1, clone 29E.2A3.C6, Azide Free - 3217074 3217074
      Anti-PD-L1, clone 29E.2A3.C6, Azide Free - 3393261 3393261
      Anti-PD-L1, clone 29E.2A3.C6, Azide Free - 3808639 3808639
      Anti-PD-L1, clone 29E.2A3.C6, Azide Free - 3946449 3946449
      Anti-PD-L1, clone 29E.2A3.C6, Azide Free - 4038975 4038975
      Anti-PD-L1, clone 29E.2A3.C6, Azide Free Monoclonal Antibody 2909532
      Anti-PD-L1, clone 29E.2A3.C6, Azide Free Monoclonal Antibody 2990475
      Anti-PD-L1, clone 29E.2A3.C6, Azide Free Monoclonal Antibody 3122202

      Produits & Applications associés

      Related Products

      Référence Description  
      ABC324 Anti-PDL-1 Antibody Prix & Disponibilité
      ABF133 Anti-PD-L1 Antibody/CD274 Prix & Disponibilité
      MABC290 Anti-PDL-1/CD274 Antibody, clone 3F2.1 Prix & Disponibilité

      Catégories

      Life Science Research > Antibodies and Assays > Primary Antibodies